About The Conference

The 8th International Prostate Cancer Symposium and World Urologic Oncology is one of the premier international meetings dedicated to advancing the science and practice of urologic oncology. Bringing together world renowned surgeons, researchers, and innovators, the symposium offers three immersive days of cutting edge education, multidisciplinary collaboration, and groundbreaking surgical innovation.

​

Designed for urologists, oncologists, surgeons, researchers, residents, fellows, and medical students, this three day educational experience showcases the latest advances in urologic oncology, robotic surgery, and translational research.

Explore the newest developments in the diagnosis and treatment of prostate, kidney, and bladder cancer through an outstanding scientific program featuring internationally recognized faculty, evidence based lectures, expert panel discussions, immersive 3D surgical video presentations, live surgical demonstrations, simulation laboratories, and interactive educational sessions.

​

With more than 80 internationally renowned speakers, attendees will gain practical insights into emerging technologies, evolving surgical techniques, multidisciplinary patient care, and the research shaping the future of urologic oncology. The symposium also provides valuable opportunities to collaborate, exchange ideas, and build lasting professional connections with leaders from around the world.

​​

​

Educational Objectives

1. Upon completion of this symposium, participants will be able to:

2. Apply the latest evidence based strategies for screening, diagnosis, and risk assessment of prostate cancer.

3. Evaluate contemporary treatment approaches for localized, locally advanced, and metastatic prostate, kidney, and bladder cancers.

4. Incorporate emerging technologies and robotic surgical innovations into clinical practice.

5. Recognize and address the technical challenges associated with complex robotic urologic oncology procedures.

6. Analyze current research and clinical evidence to improve surgical decision making and patient outcomes.

7. Discuss multidisciplinary approaches to managing treatment resistant and recurrent urologic malignancies.

8. Explore innovations in translational and basic science research that are shaping the future of urologic oncology.

 

​

Target Audience

This symposium is designed for healthcare professionals involved in the diagnosis, treatment, research, and education of patients with urologic cancers, including:

​

• Urologists

• Urologic Oncologists

• Medical Oncologists

• Radiation Oncologists

• Surgeons

• Diagnostic and Nuclear Radiologists

• Pathologists

• Genomic Medicine Specialists

• Researchers and Scientists

• Fellows

• Residents

• Medical Students

• Healthcare Professionals with an interest in urologic oncology